CLINICAL_TRIALS
trial_result
· 2024-03-22
Clinical Trial Update: RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers [EARLY_Phase 1]
Summary
Early-phase (Phase 1) trial update evaluating radioiodine (RAI) plus immunotherapy for recurrent/metastatic thyroid cancer; results were posted on 2024-03-22.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Thyroid Cancer | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-03-22